09/12/2023

Top Business

Trend About Business

Sobi’s hemophilia A therapy gets review in EU

Sobi’s hemophilia A therapy gets review in EU

Sobi’s hemophilia A therapy gets review in EU

Md Saiful Islam Khan

The European Medicines Agency (EMA) has accepted and validated Swedish Orphan Biovitrum’s (Sobi) (OTCPK:BIOVF) application seeking approval of hemophilia A therapy efanesoctocog alfa.

Sobi and Sanofi (NASDAQ:SNY) have a collaboration for efanesoctocog alfa, which was approved under the name Altuviiio in the U.S. in February